Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by PBaelishh


V.CZO

RE:RE:RE:RE:RE:RE:Unpack

I hear you. Charlie Munger used to say if you mix terds with raisins, you...

December 14, 2023

V.CZO

RE:RE:RE:Unpack

Lipstick on a pig. Gagnon just bought more time to burn cash and overpay...

December 14, 2023

V.CZO

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:As expected Sigrun is out

...and so the ample, meaningless, press releases begin.  It's as if...

December 13, 2023

V.CZO

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:As expected Sigrun is out

Too late, market has Ceapro priced BELOW break-up....

December 12, 2023

V.CZO

RE:RE:RE:RE:RE:RE:As expected Sigrun is out

Without sales volumes bein disclosed, lack of guidance - Q3 just released and...

December 12, 2023

V.CZO

RE:RE:RE:Proph, What is the job of a Revenue Officer?

Thing is, as you know, hiring a CRO does not equate to hiring a magician who...

November 30, 2023

V.CZO

RE:RE:Failure, again.

...WHILE the PGX PATENT marches towards EXPIRING.  Is there even 3 years...

November 29, 2023

V.CZO

RE:Another disappointing quarter

The base business is EVERYTHING... the only thing Ceapro has... had. I hate...

November 29, 2023

V.CZO

RE:RE:The big one...

Agreed. Gagnon - and his CFO - are terrible with the statement Notes. ...

November 29, 2023

V.CZO

RE:RE:New Press Release - Ceapro Inc. Reports 2023 Third Quarter and Nine-Month Financial Results and Operational Highlights

1. SALES VOLUMES Q1 Results, Gagnon blathered: "This includes minimum...

November 29, 2023

V.CZO

RE:Earnings disaster pending?

Another day, no Q3 released... come out, come out wherever you are Gilles...

November 28, 2023

V.CZO

RE:RE:RE:New Press Release - Ceapro Inc. Initiates Phase 1-2a Study Assessing Its Flagship Product Avenanthramides for Potential Applications in Inflammation Based Diseases

Ceapro will be fully out of cash well before September 2024... ONCE WE HAVE...

November 27, 2023

V.CZO

Regulators... hello?

CZO trades in the US and Canada are there any regulators reading this board? ...

November 27, 2023

V.CZO

RE:This is just soooo ugly

Share price now at break-up value as at end of Q2... 24.5. Nothing much to...

November 24, 2023

V.CZO

RE:20s

Twenny-nine, Twenny-nine! Do I hear Twenny-eight?  Twenny-eight...

November 8, 2023

V.CZO

RE:RE:RE:Re: Oh oh here we go again

Tomorrow never comes... Or in Gagnon's case, the answer is always, "...

November 7, 2023

V.CZO

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:CZO Smallcap Discoveries Condference Oct 11, 2023

I couldn't have said it better myself... was Gagnon looking for investors...

November 7, 2023

V.CZO

RE:RE:Donville Kent

"But then again no real excitement here..." Just a lot of real...

November 1, 2023

V.CZO

RE:Weekly analysis Ceapro + The Returns at Ceapro

Ceapro is worth nothing more than a being a case study demonstrating the...

October 30, 2023

V.CZO

RE:"Goodbye Media Coverage"

It's a classic play for a graduate of the DuMaurier School of Business at...

October 25, 2023

Prev 1 2 3 4 5 6 7 Next

Featured Company